Human disease modeling using somatic gene transfer

Details Human disease modeling using somatic gene transfer Human disease modeling using somatic gene transfer

2006-08-29

2006-08-29

Falk, Anne-Marie (Department: 1632)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

The nonhuman animal is a model for human disease

C800S012000

Reexamination Certificate

active

07098374

ABSTRACT:
This invention provides a system for modeling neurodegenerative and other diseases through somatic gene transfer. In addition, methods of multiple gene transfer, disease analysis and drug testing are provided for.

REFERENCES:
patent: 5720720 (1998-02-01), Laske et al.
patent: 6027931 (2000-02-01), Natsoulis et al.
patent: 6071889 (2000-06-01), Weiss et al.
patent: WO 99/61066 (1999-12-01), None
Hammer et al. (1990) Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta-2 microglobulin. Cell 63: 1099-1112.
Houdebine, LM (1994) Production of pharmaceutical proteins from transgenic animals. J. Biotechnology 34: 269-287.
Kappel et al. (1992) Regulating gene expression in transgenic animals. Curr. Opinion in Biotechnology 3: 548-553.
Mullins et al. (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541-544.
Mullins et al. (1989) Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice. EMBO J. 8(13): 4065-4072.
Sigmund (2000) Viewpoint: Are studies in genetically altered mice out of control? Arterioscler. Thromb. Vasc. Biol. 20: 1425-1429.
Strojek and Wagner (1988) The use of transgenic animal techniques for livestock improvement. Genetic Engineering: Principles and Methods 10: 221-246.
Taurog et al. (1988) HLA-B27 in inbred and non-inbred transgenic mice. J. Immunol. 141(11): 4020-4023.
Wall, RJ (1996) Transgenic livestock: Progress and prospects for the future. Theriogenology 45: 57-68.
Gotz et al. (2001) Tau filament formation in transgenic mice expressing P301L Tau. J. Biol. Chem. 276(1): 529-534.
Lewis et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau proteint. Nature Genetics 25: 402-405.
Klein, Ronald, L. et al., “Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostiatal Pathway by Recombinant Adeno-associated Virus Vectors”,Experimental Neurology,1998, 183-194: 150, Academic Press.
Klein, Ronald, L. et al., “Long-Term Action of Vector-Derived Nerve Growth Factor or Brain-Derived Neurotrophic Factor on Choline Acetyltransferase and TRK Receptor Levels in the Adult Casal Forebrain”,Neuroscience,1999, 815-821: 90-3, Elsevier Science Ltd., Great Britain.
Klein, Ronald, L. et al., “Prevention of 6-hydroxydopamine-induced Rotational Behavior by BDNF Somatic Gene Transfer”,Brain Research,1999, 314-320, Elsevier Science.
Price, Donald, L. et al., “Genetic Neurodegenerative Diseases: The Human Illness and Transgenic Models”,Science,1998 , 1079-1083: 282.
Hsiao, Karen, et al., “Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice”,Science,1996, 99-10: 274.
Duff, Karen, et al., “Increased Amyloid-β42(43) in Brains of Mice Expressing Mutant Presenilin 1”,Nature,1996, 710-713: 383.
Parimala, Nacharaju, et al., “Accelerated Filament Formation From Tau Protein With Specific FTDP-17 Missence Mutation”,FEBS Letters,1999, 195-199:447 , Federation of European Biomedical Societies.
Polymeropoulos, Mihael, et al., “Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease”,Science,1997, 2045-2047: 276.
Kruger, Rejko, et al., “Ala30Pro Mutation in the Gene Encoding α-synuclein in Parkinson's Disease”,Nature Gentics,1998, 106-108:18.
Abeliovich, Asa, et al., “Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System”,Neuron,2000, 239-252: 25, Cell Press.
Dickinson, Dennis, W., et al., “Tau and Synuclein and Their Role in Neuropathology”,Brain Pathaology,1999, 657-661: 9.
Buxbaum, Joseph, D., et al., “Expression of APP in the Brains of Transgenic Mice Containing the Entire Human APPGene”,Boichemical and Biophysical Research Communications,1993, 639-645, 197:2, Academic Press, Inc.
Higgins, L.S., et al., “Transgenic Mouse Brain Histopathology Resembles Early Alzheimer's Disease”,Ann Neurol,1994, 598-607: 35, American Neurological Association.
Laferla, Frank, M., et al., “The Alzheimer's Aβ Peptide Induces Neurodegenration and Apoptotic Cell Death in Trasgenic Mice”,Nature Genetics,1995, 21-30: 9.
Lamb, Bruce, T., et al., “Introduction and Expression of the 400 KilobasePrecursor Amyloid ProteinGene in Transgenic Mice”,Nature Genetics,1993, 22-30: 5.
Moran, Paula, M., et al., “Age-related Learning Deficits in Transgenic Mice Expressing the 751-Amino Acid Isoform of Human β-amyloid Precursor Protein”,Proc. Natl. Acad. Sci.,1995, 5341-5345: 92.
Hsiao, Karen, K. et al., “Age-related CNS Disorder and Early Death in Transgenic FVB/N Mice Overexpressing Alzheimer Amyloid Precursor Proteins”,Neuron,1995, 1203-1218: 15, Cell Press.
Nalbantoglu, J. , et al, “Impaired Learning and LTP in Mice Expressing the Carboxy Terminus of the Alzheimer Amyloid Precursor Protein”,Nature,1997, 500-505: 387.
Lamb, Bruce, T. et al., “Altered Metabolism of Familial Alzheimer's Disease-linked Amyloid Precursor Protein Variants in Yeast Artificial Chromosone Transgenic Mice”,Human Molecular Genetics,1997, 1535-1541, 6: 9, Oxford University Press.
Kammesheidt, Anja, et al, “Depositon of β/ A4 Immunoreactivity and Neuronal Pathology in Transgenic Mice Expressing the Carboxyl-Terminal Fragment of the Alzheimer Amyloid Precursor in the Brain”,Proc. Natl. Acad. Sci.,1992, 10857-10861: 89, USA.
Peel, Alyson, L. and Klein, Ronald, L., “Adeno-associated Virus Vectors: Activity and Applications in the CNS”,Journal of Neuroscience Methods,2000, 95-104:98, Elsevier Science.
Klein, Ronald, L. et al., “NGF Gene Transfer to Intrinsic Basal Forebrain Neurons Increases Cholinergic Cell Size and Protects From Age-Related, Spatial Memory Deficits in Middle-Aged Rats”,Brain Research,2000, 144-151: 875, Elsevier Science.
Klein, Ronald, L. et al., Adeno-Associated Virus Vector Mediated Gene Transfer to Somatic Cells in the Central Nervous System,Advances in Virus Res.Edited by K. Maramorosch, F.A. Murphy, A.J. Shatkin, J.C. Glorioso, 2000, 507-528: 55, Academic Press, SanDiego.

Affiliated with

Also associated with

Rating

Human disease modeling using somatic gene transfer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human disease modeling using somatic gene transfer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human disease modeling using somatic gene transfer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3717361